September 4th, 2007
The experimental compound cyclopamine was previously known to shut down a critical cell-signaling pathway (Hedgehog) in the most common and aggressive type of adult brain cancer: glioblastoma multiforme.
Now, according to Johns Hopkins scientists, cyclopamine have been able to successfully kill cancer stem cells thought to fuel tumor growth and help cancers evade drug and radiation […]
By Gloria Gamat -- 0 comments
January 19th, 2007
Gliomas are the scariest group of brain tumors, the most common type of which is the most aggressive.
Malignant gliomas are least affected by chemotherapy and radiation. Patients only survive a year after diagnosis.
Shedding light into this seeming hopeless, fatal condition, Lund University (Sweden) research suggests that stem cells from the brain can be developed to […]
By Gloria Gamat -- 1 comment
September 14th, 2006
U.S. researchers have recently reported that in children with brain tumors called medulloblastomas, a highly targeted treatment that relies on the patient’s own stem cells led to improved outcomes: from 30-40% chance of surviving to five years to 70-80%.
Chemotherapy usually lasts for 12 months. In this new treatment regimen, radiation therapy is tailored to the […]
By Gloria Gamat -- 0 comments
Recent Comments